Virology, epidemiology and diagnosis of genital herpes;Virologie, epidemiologie und diagnostik des herpes genitalis

Deutsche Medizinische Wochenschrift

Volumn 124, Issue 6, 1999, Pages 158-162

  Chenot, Jean Francois ^a   Rabenau, Holger Felix ^a   Doerr, Hans Wilhelm ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; FAMCICLOVIR; FOSCARNET SODIUM; VALACICLOVIR; VIDARABINE;

ADOLESCENT; ADULT; CHILD; DRUG EFFICACY; GENITAL HERPES; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MOLECULAR BIOLOGY; ORAL DRUG ADMINISTRATION; PATHOGENESIS; REVIEW; VIROLOGY;

EID: 0033548121     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024268     Document Type: Review

References (31)

1. Ashley, R. L., I. Wu, J. W. Pickering, M. C. Tu, L. Schnorenberg: Premarket evaluation of a commercial glycoprotein g-based enzyme immunoassay for herpes simplex virus type-specific antibodies. J. clin. Microbiol. (1998), 294-295.
2. Bahrdt, B., H. Rabenau, B. Weber, J. Eibner, H. W. Doerr: Prävalenz Herpes-simplex-Virus-Typ-2-spezifischer Antikörper bei Personen mit unterschiedlichen Infektionsrisiko Z. Hautkr. 67 (1) (1992), 56-58.
3. Bischoff, A.: Wenn Liebe schmerzt. Münch. med. Wschr. 140 (1998), 16-18.
4. Coen, D. M., P. A. Schaffer: Two distinct loci Confer resistance to acylguanosine in herpes simplex virus type 1. Proc. nat. Acad. Sci. USA 77 (1980), 2265-2269.
5. Corey, L., E. F. Stone, Z. A. Brown, K. K. Holmes: Genital herpes simplex infection: clinical course, and complications. Ann. Intern. Med. 98 (1983), 958-972.
6. Dannenmaier, B., W. Alle, E. W. Hoferer, D. Lorenz, P. J. Oertl, H. W. Doerr: Incidences of antibodies to hepatitis B, herpes simplex and cytomegalovirus in prostitutes. Zbl. Bakt. Hyg. 259 (1985), 275-283.
7. Doerr, H. W., G. Gross, H. Schmitz: Neutralizing serum antibodies in infections with herpes simplex virus hominis. Med. Microbiol. Immunol. 162 (1976), 183-192.
8. Doerr, H. W., H. Lehmair, H. Schmitz, D. Kampa, T. Luthardt: Simple mathematical deductions in the seroepydemiology of viral infections I (Herpesvirus group (Herpesvirus hominis, Varicella-Zoster-Virus, Cytomegalovirus, Epstein-Barr-Virus). Zbl. Bakt. Hyg. 238 (1977), 149-164.
9. Doerr H. W., H. Rabenau: Dermatotrope Herpesviren, Infektionsbiologie, Epidemiologie und Diagnostik. Chemotherapie Journal 1 (1996), 1-11.
10. Dragavon, J., E. Peterson, R. L. Ashley, F. Lafferty, L. Corey: Routine typing of herpes virus isolates. Diagn. Infect. Dis. 3 (1985), 269-270.
11. Dueland, A. N., T. Ranneberg-Nilsen, M. Degre: Detection of latent varicella zoster virus DNA and human gene sequences in human trigeminal ganglia by in situ amplification combined with in situ hybridization. Arch. Virol. 140 (1995), 2055-2066.
12. Fleming D. T., G. M. McQuillan, R. E. Johnson, A. J. Nahmias, S. O. Aral, F. K. Lee, M. E. Louis: Herpes simplex type 2 in the United States, 1976 to 1994. New Engl. J. Med. 377 (1997), 1105-1111.
13. Groen J., G. Dijk, H. v. Niesters, W. Meijden, A. v. d. Osterhaus: Comparison of two enzyme-linked immunosorbent assays and one rapid immunoblot for the detection of herpes simplex virus type 2-specific antibodies in serum. J. clin. Microbiol. 36 (1998), 845-847.
14. Gröschel B., J.-U. Vogel: Wie die antivirale Therapie gegen genitalen Herpes heute aussieht. Forschung u. Praxis 228 (1996), 10-13.
15. Hwang, C. B., B. Horsburgh, E. Pelosi, S. Roberts, P. Digard, D. M. Coen: A net+ 1 frameshift permits synthesis of thymidine-kinase from drug resistant herpes simplex virus mutants. Proc. nat. Acad. Sci. USA 91 (1994), 5461-5465.
16. Kohl, S.: Neonatal herpes simplex infection. Clin. Perinatol. 24 (1997), 129-150.
17. Martin J.L., M. N. Ellis, P. M. Keller, K. K. Biron, D. W. Lehrman, D. W. Barry, P. A. Furman: Plaque autoradiography assay for the detection and quantitation of thymidinekinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates. Antimicrob. Agents Chemother. 38 (1985), 1246-1250.
18. Meier J. L., S. E. Strauss: Comparative biology of latent varicella-zoster virus and herpes simplex virus infection. J. infect. Dis. 166 (1992), 19-36.
19. Rabenau H., B. Eibner, B. Weber, B. Bahrdt, H. W. Doerr: Detection of herpes simplex virus (HSV) type specific antibodies by a microtechnique western blot assay. Lab. Med 16 (1992), 327-333.
20. Rabenau H., B. Weber, J. Cinatl, G. Bauer, H. W. Doerr: Automatisierte In vitro-Empfindlichkeitstechniken von klinischen Herpes-simplex-Virus-(HSV)-Isolaten mit Hilfe eines In-situ-ELISAs. Chemotherapie Journal 4 (1996), 204-208.
21. Roizman, B., A. E. Sears: Herpes-simplex-virus and their replication. In Fields (ed.): Virology (Lipincott-Raven: Philadelphia 1996), 2231-2295.
22. Safri S.: Herpes simplex and varicella zoster virus infection in HIV-infected individuals. In Broder S., T. C. Merigan, D. Bolognesi (Eds.): Textbook of AIDS Medicine (Williams & Wilkins: Baltimore 1994) 373-383.
23. Sakrauski A., B. Weber, H. H. Kessler, K. Pierer, H. W. Doerr: Comparison of two hybridization assays for the rapid detection of PCR and amplified HSV genome sequences from cerebrospinal fluid. J. Virol. Meth. 50 (1994), 175-184.
24. Schieferstein C.: Typenspezifische Herpes simplex Virus-Antikörper: Vergleich verschiedener ELISA-Testsysteme und eines Western blot. Lab. Med. 21 (29) (1997), 107-118.
25. Schneeweis K. E.: Epidemiologie von Herpes simplex-Erkrankungen. Z. Hautkr. 52 (7) (1976), 427-432.
26. Sucato G., A. Wals, E. Wakabayashi, J. Vieira, L. Corey: Evidence of latency and reactivation of both herpes simplex virus (HSV)-1 and HSV-2 in the genital region. J. infect. Dis. 177 (1998), 1069-1072.
27. Swetter S. M., E. L Hill, E. R. Kern, D. M. Koelle, C. M. Posavad, W. Lawrence, S. Safrin: Chronic vulvar ulceration in an immunocompetent woman due to acyclovir resistant, thymidine kinase-deficient herpes simplex virus. J. infect. Dis. 177 (1998), 543-550.
28. Tebas P., E. C. Stabell, P. D. Olivio: Antiviral susceptibility testing with a cell line which expresses β-galactosidase after infection with herpes simplex virus. Antimicrob. Agents. Chemother. 39 (1995), 1287-1291.
29. Vogel J. U., B. Weber, H. W. Doerr: Typing and strain differentiation of clinical herpes simplex virus type 1 and 2 isolates by polymerasse chain reaction and subsequent restriction fragment length polymorphism analysis. Zbl. Bakt. 281 (1994), 502-512.
30. Weber B., J. Cinatl: Antiviral therapy of herpes simplex virus infection: recent developments. J. Europ. Acad. Derm. Venerol. 6 (1996), 112-126.
31. Wutzler P., H. W. Doerr, J. Essen, G. Gross, W. Höbel, J.-P. Malin, A. Meister, A. Neiß, B.-Y. Reimann, C. Witke: Epidemiology of herpes zoster. Biotest Bulletin 5 (1997), 301-306.